Vincent G. Zannoni

Hepatic microsomal epoxidation of bromobenzene to phenols and its toxicological implication.

Abstract In vitro microsomal hepatic epoxidation of bromobenzene in rats and mice is presented in this study. Formation of o-bromophenol via bromobenzene-2,3-epoxide and p-bromophenol via bromobenzene-3,4-epoxide was assayed enzymatically and identified by a new, rapid and sensitive gas-liquid chromatography method using electron capture detection. Pretreatment of the animals with phenobarbital caused significant increases in both pathways whereas 3-methylcholanthrene or β-naphthoflavone caused a selective and marked increase of only the 2,3-epoxide pathway. Sodium dodecyl sulfate-gel electrophoresis of microsomal preparations resolved multiple forms of cytochrome P-450 and indicated that different forms of the heme protein were responsible for the formation of o-bromophenol and p-bromophenol. it is of interest that various inducers augment particular pathways for a common substrate especially since bromobenzene-3,4-epoxide and not the bromobenzene-2,3-epoxide has been proposed as the cytotoxic reactive metabolite of bromobenzene.

Effect of ascorbic acid on the consequences of acute alcohol consumption in humans

This study examines the influence of ascorbic acid pretreatment on ethanol clearance, toxicity, and behavioral impairment after an acute dose of ethanol in humans. Ascorbic acid or a placebo was given to 20 healthy male subjects for 2 weeks before ethanol consumption. The dose of ethanol was 0.95 gm/kg body weight and was consumed during a 2½‐hour period. Thirty minutes after ethanol consumption, motor coordination and intellectual function were assessed by Goldbergs “Finger‐Finger” and “Serial Sevens” tests. In addition, color discrimination was measured with the use of the Farnsworth‐Munsell 100 Hue Color Test. Hourly blood samples were taken for 10 hours after ethanol consumption to measure serum triglyceride levels, blood lactate/pyruvate ratios, and serum enzymes. Blood ethanol clearance was also determined. Ethanol consumption elevated serum triglyceride levels and blood lactate/pyruvate ratios and impaired performance of the behavioral tests but did not alter serum enzyme levels. Ascorbic acid pretreatment resulted in significant enhancement in blood ethanol clearance and an increase in serum triglyceride levels after ethanol consumption in half of the subjects. Ascorbic acid pretreatment also resulted in improved motor coordination and color discrimination after ethanol consumption in half of the subjects. Ascorbic acid pretreatment did not influence elevated blood lactate/pyruvate ratios or impaired intellectual function.

Ascorbic Acid and Chronic Alcohol Consumption in the Guinea Pig

Protection against the toxic effects of chronic alcohol consumption was observed in male guinea pigs maintained on a high-ascorbic-acid diet (vitamin C-deficient chow plus 2.0 mg ascorbic acid/ml drinking water) as compared to animals on a low-ascorbic-acid diet (vitamin C-deficient chow and from 0.025 to 0.050 mg ascorbic acid/ml drinking water). Alcohol was orally administered to the guinea pigs at a dose of 2.5 g/kg for up to 14 weeks. Levels of serum aspartate aminotransferase and serum alanine aminotransferase were significantly elevated in animals on the low-ascorbic-acid diet that received alcohol, 120 and 250%, respectively. In contrast, in animals on the high-ascorbic-acid diet that received alcohol, levels of alanine aminotransferase were not significantly elevated and levels of aspartate aminotransferase were elevated 50%. In addition, some of the animals on the low-ascorbic-acid diet that received alcohol for 12 to 14 weeks developed hepatic steatosis and necrosis, whereas none of the animals on the high-ascorbic-acid diet that received alcohol for the same length of time manifested these changes.

Ascorbic acid and heme synthesis in deficient guinea pig liver

1x. E. Darzynkiewicz. Z. Karimierczuk and D. Shugar. Ctrrrcer Bio(.h~‘/t7. Biophys. 1. 203 (1976). E. De Clercq. E. Darrynkiewicz and D. Shugar, Bioc/retrr. P/~u~uu. 24. 523 (1975). M. Fiala. A. W. Chow, K. Miyasaki and L. B. Guze. J. /r~fec,t. Dis. 129. 82 (1974). M. I. Marks. .4rltirnicroh. Ay. Chrmother. 6, 34 (1974). E. R. Kern. J. C. Overall. Jr. and L. A. Glasgow, Antim~cwh. A!/. Cl~rrtror/w. 7. 5X7 (1975). G. Freeman. A. Kuehn and 1. Sultanian, Atur. N.Y. ./lc&. Sci. 130. 330 (1965). J. B. Campbell. R. F. Maes, T. J. Wiktor and H. Koprowski. l’iro/o!/r 34. 701 (1968). 19. J. A. Grant and L. R. Sabina. Antitnicroh. ilcj. Chrmother. 2. 201 (1972). 20. T. Ben-Porat. McK. Brown and A. S. Kaplan Molec. P/tar,nac. 4. I39 (I 968). 21. C. Shipman, Jr., S. H. Smith, R. H. Carlson and J. C. Drach. Antimcroh. Ag. Chemothrr. 9. 120 (1976). 22. J. A. Montgomery and A. G. Laseter. J. rrrud. C/rem. 17. 360 (1974). 23. J. Giziewicr. E. De Clercq. M. Luczak and D. Shugar. Eiochrrn. Phwac. 24. IX I3 ( 1975).

Effect of Ascorbate on Covalent Binding of Benzene and Phenol Metabolites to Isolated Tissue Preparations

[14C]Phenol and [14C]benzene are metabolized in the presence of NADPH and hepatic microsomes isolated from phenobarbital- or benzene-pretreated or untreated guinea pigs to intermediates capable of covalently binding to microsomal protein. When 1 mM ascorbate was included in the incubation mixture containing benzene as the substrate, covalent binding was inhibited by 55%. Increasing the ascorbate concentration to 5 mM inhibited binding by only an additional 17%. In contrast, when phenol was used as the substrate, 1 mM ascorbate inhibited binding by 95%. When DT-diaphorase was included in the incubation mixture containing benzene as the substrate, binding was inhibited by only 18%. This degree of inhibition is in contrast to 70% inhibition with phenol. These results indicate that different metabolites are responsible for a portion of the covalent binding depending upon the substrate employed. GSH inhibited covalent binding greater than 95% with either substrate. The metabolism of phenol to hydroquinone was unaffected by the addition of ascorbate or GSH. The metabolism of benzene to phenol was unaffected by the addition of GSH; however, the addition of ascorbate decreased the formation of phenol by 35%. Tissue ascorbate could be modulated by placing guinea pigs on different dietary intakes of ascorbate. Bone marrow ascorbate concentrations could be modulated 10-fold without any significant change in the GSH concentrations. Bone marrow isolated from guinea pigs on different dietary intakes of ascorbate were incubated with H2O2 and phenol. Bone marrow with low ascorbate concentrations displayed 4-fold more covalent binding of phenol equivalents than those with high ascorbate concentrations. This is an example of how the dietary intake of ascorbate can result in a differential response to a potentially toxic event in vitro.

Ascorbic acid deficiency and the flavin-containing monooxygenase

Activity of the flavin-containing monooxygenase (FMO) was reduced significantly in ascorbic acid deficient guinea pigs. Reduction in oxidation of dimethylaniline (DMA) and of thiobenzamide was associated with a decrease in the activity of the FMO. In both ascorbate supplemented and deficient guinea pig hepatic 12,000 g supernatant fractions, SKF-525A and n-octylamine did not inhibit DMA N-oxidation. Phenobarbital pretreatment did not increase the rate of N-oxidation of DMA. In addition, hepatic supernatant fractions thermally treated at 50 degree were unable to N-oxidize DMA, but 80% of the cytochrome P-450 activity was retained. Also, N-oxidation of DMA was reduced by 53% at pH 7.0, while oxidation of cytochrome P-450 specific substrates was inhibited by only 19%. Kinetic studies of DMA N-oxidation indicate no significant change in the apparent Km in ascorbate supplemented or deficient animals. The in vitro addition of ascorbic acid had no effect on the activity of the FMO. The toxicological implications of the reduction in FMO activity in ascorbic acid deficiency are discussed.

Ascorbic acid and alcohol oxidation

Methanol and ethanol were rapidly metabolized to formaldehyde and acetaldehyde in the presence of ascorbate, 1,10-phenanthroline and either guinea pig hepatic 100,000 g supernatant or 12,000 g pellet fractions. The specific activity of methanol oxidation was 1720 nmoles formaldehyde formed/min/mg protein in the 100,000 g fraction and 790 in the 12,000 g pellet fraction. The specific activity of ethanol oxidation was 1590 nmoles acetaldehyde formed/min/mg protein in the 100,000 g fraction and 820 in the 12,000 g pellet fraction. The activity was enzymatic in that it was linear with time, proportional to protein concentration, and sensitive to temperature. Catalase appeared to be the enzymatic component responsible for the oxidation. In this ascorbate-dependent alcohol oxidation system, oxygen was consumed and H2O2 was formed. When purified catalase and ascorbate were used, complex I was detected and methanol was oxidized.

FLAVIN-CONTAINING MONOOXYGENASE AND ASCORBIC ACID DEFICIENCY QUALITATIVE AND QUANTITATIVE DIFFERENCES*

Ascorbic acid deficiency causes qualitative and quantitative differences in the guinea pig hepatic flavin-containing monooxygenase (FMO). Kinetic studies with purified FMO indicated no significant change in the apparent Km of dimethylaniline or NADPH in ascorbate-supplemented or -deficient animals. Following purification of ascorbate-deficient guinea pig FMO by DEAE-cellulose and blue agarose chromatography, exogenous FAD was required for 15% of the FMO microsomal activity recovered. In contrast, only 5% of the total microsomal enzyme recovered from ascorbate-supplemented animals required exogenous FAD. Furthermore, there was an enhanced sensitivity to time-dependent nonlinearity with the purified ascorbate-deficient guinea pig FMO. The degree of time-dependent nonlinearity was related to the concentration of substrate. Also, purified ascorbate-supplemented guinea pig FMO was stable for 4 weeks at -20 degrees, whereas the ascorbate-deficient enzyme was inactivated. A decrease in the quantity of ascorbate-deficient guinea pig FMO compared to ascorbate-supplemented was indicated by a marked reduction in total FMO activity recovered from blue agarose chromatography and reduced protein staining intensity with SDS-PAGE at 56,000 daltons.

Ascorbic acid deficiency and hepatic UDP-glucuronyl transferase. Qualitative and quantitative differences.

The effect of dietary ascorbate on hepatic UDP glucuronyltransferase (UDPGT) appears to be selective in that only certain isozymes of UDPGT are jeopardized. In this study, ascorbic acid deficiency produced a 68% reduction in the specific activity of hepatic UDPGT towards p-nitrophenol. Earlier studies showed a reduction in UDPGT activity towards p-aminophenol in ascorbate-deficient guinea pigs, whereas bilirubin and acetaminophen glucuronidation were unaffected. Kinetic studies suggest that p-aminophenol and p-nitrophenol are metabolized by a single isozyme in that p-nitrophenol was found to be a competitive inhibitor of p-aminophenol glucuronidation. Both qualitative and quantitative studies on partially purified UDPGT from ascorbate-deficient and ascorbate-supplemented guinea pigs were carried out to investigate the biochemical role of the vitamin. Qualitative differences were observed in UDPGT from ascorbate-deficient animals and included an increased lability to: thermal inactivation; storage at 4 degrees; and purification with UDP-glucuronic acid agarose column chromatography. Furthermore, an analysis of the microsomal membrane showed a 14% increase in membrane fluidity in ascorbate deficiency. Ascorbic acid added in vitro could not reverse the increase in fluidity observed in ascorbate-deficient microsomal membranes; however, ascorbylpalmitate, a more lipophilic form of the vitamin, was effective. Palmitic acid had no effect on membrane fluidity in microsomes from either the ascorbate-supplemented or ascorbate-deficient animals. This increase in membrane fluidity could not be explained by differences in cholesterol, total phospholipid, or phosphatidylcholine content of hepatic microsomes. Furthermore, a quantitative reduction in UDPGT partially purified from ascorbate-deficient guinea pigs was indicated by a marked reduction in protein banding at 55,000 daltons when compared to UDPGT partially purified from ascorbate-supplemented animals.